KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Invested Capital: 2016-2024

Historic Invested Capital for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Dec 2024 value amounting to $2.3 billion.

  • Amneal Pharmaceuticals' Invested Capital rose 7.09% to $2.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 billion, marking a year-over-year increase of 7.09%. This contributed to the annual value of $2.3 billion for FY2024, which is 6.71% down from last year.
  • Amneal Pharmaceuticals' Invested Capital amounted to $2.3 billion in FY2024, which was down 6.71% from $2.4 billion recorded in FY2023.
  • Amneal Pharmaceuticals' Invested Capital's 5-year high stood at $3.1 billion during FY2020, with a 5-year trough of $2.3 billion in FY2024.
  • In the last 3 years, Amneal Pharmaceuticals' Invested Capital had a median value of $2.4 billion in 2023 and averaged $2.5 billion.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Invested Capital rose by 4.94% in 2020 and then decreased by 13.04% in 2023.
  • Yearly analysis of 5 years shows Amneal Pharmaceuticals' Invested Capital stood at $3.1 billion in 2020, then declined by 1.50% to $3.1 billion in 2021, then decreased by 8.83% to $2.8 billion in 2022, then fell by 13.04% to $2.4 billion in 2023, then decreased by 6.71% to $2.3 billion in 2024.